Financial Shenanigans

Financial Shenanigans — Forensic risk read

Reported earnings at Isetan Mitsukoshi look better than the underlying business in three specific, disclosed ways — a one-off Shin Kong stake sale that contributed ¥10,646M of pre-tax gain to FY26 reported net income [1]; a sequence of deferred-tax swings that distorted the bottom line by ¥9.6B (benefit) in FY24 and ¥15.0B (charge) in FY25 [2]; and a ¥773M bad-debt allowance reversal in FY25 H1 that management itself flags as the reason FY26 H1 credit-segment profit declined year-on-year [3]. Importantly, management discloses each of these items, calls them what they are ("irregular" / "特殊要因"), and runs an internal "ex-specials" KPI that lands on roughly 10% ROE versus the headline 12.3% [4]. That transparency, combined with strong cash conversion and a long-tenured but disclosed audit relationship, is what keeps this in the Watch band rather than further up the curve.

Forensic verdict

Forensic Risk Score (0–100)

35

Red flags

2

Yellow flags

6

3-yr CFO / Net Income

1.29

3-yr FCF / Net Income

0.82

Accrual ratio FY26

-1.2%

FY26: Receivables growth − Revenue growth

7.4%

FY26: Non-recurring share of reported NI

11.1%

Clean tests passed

5

The headline tension — three "irregular" pillars under FY26 net income

FY26 reported net income jumped 44.1% to ¥76,096M even though revenue fell 1.8% to ¥545,626M [7]. Operating profit moved only +4.9%. The 44% net-income surge is built almost entirely from items below the operating line — and management itself bridges them out.

Loading...

Three of the largest five contributors are items management itself calls "irregular" or "special": the Shin Kong stake sale [1], the absence of the FY25 ¥8,645M goodwill impairment [8], and the absence of the FY25 ¥15,025M deferred-tax catch-up [2]. The CEO acknowledged in the May 2026 briefing that the Shin Kong line is "the year-on-year comparison factor" between operating and ordinary profit and confirmed FY27 plan was set "slightly conservatively" because of it [5]. Independently, the FY27 net-income guidance of ¥61,500M (down 19.2%) is itself the company's admission that ¥14–15B of FY26 reported NI does not repeat [6].

CFO does not lean on the income statement — but it does lean on working-capital timing

Loading...

CFO has exceeded reported net income in every year of the eight-year window, including the deep COVID losses [9]. The three-year CFO/NI ratio of 1.29 and three-year FCF/NI ratio of 0.82 are clean by the standards of an asset-heavy department-store group. The accrual ratio in FY26 is negative 1.2% — i.e., cash exceeded earnings, not the other way around — so the income statement is not being padded by reserve build or capitalization tricks.

The reason CFO is not a red flag is also the reason it deserves a yellow one: the level of CFO in any given year is heavily driven by working-capital timing, especially trade receivables that swing with the credit-card subsidiary's funding cycle.

Loading...

FY25 CFO rose ¥32.7B year-on-year, but ¥33.8B of that swing came from the receivables line alone (a ¥34.1B drag in FY24 became a ¥0.3B drag in FY25) — i.e., the entire CFO uplift was a one-year normalization of a receivables build that had compressed FY24 cash collection [10]. In FY26 the headline ¥1.1B CFO improvement masked a ¥9.9B drag from a fresh receivables build and a ¥5.8B credit from extending payables [11]. The Shin Kong ¥10.6B sale gain was correctly excluded from CFO (added back in the reconciliation) and the cash flowed through investing CF [12] — no CF1 (financing-into-operating) issue.

The mechanism behind CFO is therefore named: it is genuine collection of card-finance receivables and supplier-payable timing, not a securitization or factoring scheme. But the level oscillates ¥30B+ year-to-year on those swings alone, so single-year CFO is a poor proxy for run-rate cash generation.

Revenue growth is now slower than receivables growth — DSO is drifting up

Loading...

DSO has drifted from 100 days in FY23 to 110 days in FY26, with the biggest single-year jump (+7.7 days) coinciding with the year revenue actually contracted [13][14]. The mechanism is partly visible: 株式会社エムアイカード (MI Card) is growing card-finance balances aggressively (the new annual-fee-free Basic card pushed new applications up ~40% year-on-year), so receivables on the holding-company balance sheet structurally rise [15]. This is not by itself an EM1 red flag — it is real card receivables, not channel-stuffing of department-store revenue. But it does mean DSO has lost its usefulness as a revenue-quality signal and needs to be benchmarked against card-balance growth instead.

Loading...

FY24 (receivables grew faster than revenue by 5.3 pp) and FY26 (gap of 7.4 pp, with revenue actually contracting) are the two years where a buy-side reader should ask whether the card business is masking weakness in department-store revenue cadence — even though no revenue-recognition rule is being bent.

The reserve grind — a slow drawdown that smooths the recovery

The single most underappreciated pattern in the multi-year filings is the steady erosion of every reserve line versus a recovering revenue base.

Loading...

Every reserve line on the FY25 balance sheet drifts down even as revenue grows 3.6%: doubtful-account allowance ¥4,114M → ¥3,692M, point reserve ¥2,323M → ¥2,019M, gift-card breakage reserve ¥13,242M → ¥12,177M [16]. Total reserves as a percentage of revenue fell from 6.0% to 5.4% in one year. Then in the FY26 cash-flow statement, the doubtful-account line is +¥66M (essentially zero), versus −¥773M in FY25 — i.e., the prior year had a ¥773M net release [11].

Management has, twice on the record, said out loud that this release is what is making FY26 H1 credit-segment profit look worse: "前期に発生した貸倒引当金の戻入額の影響により、当中間連結会計期間としては減益となりました" (the H1 FY26 profit decline reflects the prior-period bad-debt-reversal effect) [3], and again "前期に発生した貸倒引当金の戻入額の影響等により減益となりました" in Q3 FY26 [17]. That admission converts what would otherwise be an unverifiable yellow flag (EM5/EM6 "is the company under-reserving?") into a confirmed but transparent earnings boost.

The FY25 big-bath that cleared the runway for the FY26 surprise

Special losses in FY25 totaled ¥12,242M — almost double FY24's ¥6,203M — and concentrated in a single ¥11,229M impairment line, of which ¥8,645M was a clean-out of the goodwill carried on the "Other" segment (food-style subsidiary 株式会社エムアイフードスタイル) [7][9]. The next year, FY26, impairment dropped to ¥1,191M — a ¥10.0B year-on-year tailwind to operating profit and ordinary income that does not show up as a special item because it is the absence of one [1].

Loading...

Two complications give this a yellow rather than green flag. First, the Q3 FY26 tanshin notes that "減損損失のうち、一部を特別損失の「店舗閉鎖損失」に含めて表示しております" — some impairments are bucketed inside the "store closure" line rather than reported separately [18]. That means the impairment-loss line on its own understates the total write-down activity. Second, the goodwill was created via a step acquisition (i-Card / MI Food Style consolidation) which already produced a ¥3,810M step-acquisition gain booked as special income in FY23 — so the same set of M&A actions has now produced both a one-off gain and a clearing impairment. Big-bath risk (EM7) is therefore yellow rather than green: the company did not invent the charges, but it did concentrate them, and segment-level disclosure is not granular enough to test whether the carrying value was always low-quality.

Deferred-tax volatility is doing real work on net income

Loading...

In FY24 the effective tax rate was −0.68% — essentially zero — because a ¥9,641M deferred-tax benefit fully absorbed the current-tax charge [19][20]. In FY25 the same line flipped to a ¥15,025M charge as part of the DTA was reversed. Management itself confirmed in May 2025 that "今後は税率は30%に近づいていく" (going forward the effective rate will converge to ~30%) and that the ex-DTA, ex-special-items ROE target is "10% or more" [4] — i.e., FY24's 9.4% reported ROE was overstated and FY25's 8.8% was understated by the tax-line gymnastics.

This is not aggressive accounting in any forensic sense — DTA recognition is judgment, the company telegraphed the change, and the swings net out across three years. But it does mean that bottom-line YoY growth comparisons for FY23, FY24, FY25 and FY26 are all noisy in the same direction the company favors at that point in time, and the headline "record net income" claim for FY26 leans on ¥17B of below-the-operating-line items (Shin Kong gain + absent impairment + lower deferred-tax charge).

Capex outruns depreciation — but the gap is real investment, not capitalized opex

Loading...

Capex/D&A ran above 1.25x in FY24–FY26 after running below 1.0x through the COVID re-set [9]. Construction-in-progress on the FY25 balance sheet rose to ¥14,289M from ¥13,034M, and software intangibles held at ¥17.2B [16]. The DX / system-development bucket is sized at roughly ¥9B per year under the new mid-term plan. None of these are out of line for a department-store group rebuilding flagship stores at Shinjuku, Nihonbashi and Ginza, and SG&A has been declining absolutely (¥264,568M → ¥261,362M in FY25 [20]) — i.e., expenses are not visibly migrating into capitalized assets. EM4 (capitalizing operating costs) is green on the available data, though the disclosure does not break out internally-developed software versus purchased systems, which is the one item to watch as DX spend ramps.

The April 2026 Shin Kong divestiture is structured as a sale to 新豐資本股份有限公司 (Xin Feng Capital), a special-purpose company set up by the JV partner Shin Kong Group itself [21]. Counterparty independence is therefore limited — this is a related-party-adjacent transaction in substance, even though the SPC is technically a separate legal entity. The first tranche (Q1 FY26, ¥10,646M gain) is already booked; the second tranche (April 2026 closing) will add another ~¥10B gain in FY27 per the subsequent-events note [21]. Management explicitly says the FY27 plan only partially incorporates this — leaving room for an upside surprise the market may already be pricing in.

Separately, the FY25 yuho discloses a 40%-owned affiliate (持分法適用関連会社) with related-party transactions of ¥6,960M in FY25 versus ¥8,040M in FY24, plus director-related-party amounts of ¥26M for the CEO and smaller amounts for other executive officers [22]. These are small in absolute terms and disclosed in normal form. No EM2 (bogus revenue via affiliated customers) signal — the inter-group "連邦" (federation) revenue model is large but documented and consolidated.

Non-GAAP and KPI hygiene — management uses ex-specials, doesn't hide GAAP

In the Q4 FY25 transcript, management agreed with an analyst that the steady-state ROE target should be measured "特殊与件を除いた数字" (excluding special items) [4]. The Q4 FY26 transcript explicitly tagged the Shin Kong gain as "イレギュラーな利益" (irregular profit) and built FY27 plan around its disappearance [5]. Q3 FY26 transcript volunteered that the FY26 equity-method income spike was driven not by Shin Kong's operations but by Shin Kong booking a mark-to-market valuation gain on its own securities holdings — a second "non-recurring inside the recurring line" that few non-Japanese readers would have caught [23].

The non-GAAP hygiene flag is therefore green-leaning-yellow: management does publish a less-flattering ex-specials view in transcripts, but the headline "過去最高益" ("record net income") narrative in earnings releases and presentations does not foreground it [7]. A reader who only looks at slide 5 of the May 2026 presentation deck will see "record net income"; a reader who reads the transcript will see "irregular." Both views are honestly available — the company just lets the headline run.

The one clearly questionable comparison choice: management has used FY18 (pre-COVID, low-margin) as the baseline for "130% growth" narratives across multiple Q3 decks, rather than the more demanding FY19 or FY15 comparators. That is a KM1 yellow flag — narrative framing, not metric manipulation.

Breeding-ground — long auditor tenure, but no other amplifiers

No Results

EY ShinNihon has been the auditor since 2008 — close to 17 years by FY25 [24]. Audit fees of ¥117M are accompanied by ¥122M of non-audit fees, a ratio close to 1:1 [25]. Neither is a red flag in isolation; the combination warrants attention, especially because no audit-committee disclosure flags any KAM dispute or change in auditor stance. Board independence is healthy (6 of 9 directors independent, 66.6%) [26]. PSU compensation is linked to ROE in a 0–200% payout band, which can incentivize the kind of "ex-special-items" framing the company uses publicly, but no quarterly metric or revenue-growth gate appears to drive short-term behavior.

The breeding ground does not amplify the accounting flags above; nor does it dampen them strongly. It is best described as neutral-to-yellow.

The 13-category scorecard

No Results

The supporting citations for each row of the scorecard are woven into the prose above and into the References list below. Note that EM3 is the only red row; six rows are yellow; six are green (counted across EM, CF, KM categories above). The shape is consistent with a "Watch" forensic grade.

What to underwrite next

Five specific items, in priority order, drive whether this stays a Watch or moves:

  1. The second Shin Kong tranche (closing April 2026). Per the subsequent-events note, another ~¥10B gain is coming, with Isetan Mitsukoshi's stake dropping to 10% [21]. Test whether this is booked in 特別利益 (correct), whether the proceeds flow through investing CF, and whether management's FY27 NI guide of ¥61,500M is upgraded. If the gain is silently rolled into ordinary income or used to absorb other write-downs, that would be the single clearest red flag — and the current Watch grade would move to Elevated.

  2. Doubtful-account allowance and point/gift-card reserves in the FY26 yuho (June 2026 filing). If reserves continue to shrink while card-balance receivables grow, the EM5/EM6 yellow flags merge into a single sustained red — credit-segment earnings would be visibly under-reserved.

  3. DSO at FY27Q1 versus card-balance growth disclosure. Receivables grew 5.6% while revenue fell 1.8% in FY26. The right denominator is end-of-period MI Card outstanding credit balance, not revenue. If MI Card discloses balance growth that matches receivables, DSO drift is benign; if not, channel-stuffing or receivable extension becomes a live question.

  4. EY ShinNihon audit-fee mix in the June 2026 yuho. Non-audit fees were essentially equal to audit fees in FY25 [25]. A continued 1:1 ratio plus another year of tenure (now 18 years) is a creeping independence concern. A move to mandatory partner rotation disclosure or auditor change would be a green signal.

  5. The next time impairment exceeds ¥3B. Big-bath risk (EM7) materializes when impairments cluster around a strategic reset. The FY25 ¥11.2B charge cleared goodwill. The next strategic milestone is FY28 (start of "Phase II / 'machi-ka'" town-development phase) — watch FY27/H1 for any pre-emptive write-downs of overseas store assets (Singapore restructuring already in progress) or store-closure clusters labeled as "事業構造改革."

Implication for sizing. The forensic risk picture supports a position-sizing limiter, not a thesis breaker. Strip ¥8–10B of after-tax non-recurring income from FY26 reported NI and FY26's ¥76.1B becomes ~¥66–68B — broadly in line with the FY27 guide of ¥61.5B once you add back the smaller FY27 Shin Kong tranche. A reader paying for the headline 12.3% ROE is buying ~10% ex-specials; a reader paying for "record cash conversion" should average CFO over three years (≈¥79B) rather than annualize the FY25 spike. Apply roughly a 10–15% haircut to the trailing P/E used in screens, and reserve incremental position size for the FY27 yuho confirmation of the reserve trajectory.

References

  1. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin (Kessan Tanshin), Consolidated P&L incl. Special Items — p.11
  2. Isetan Mitsukoshi Holdings — FY2025 Full-Year Tanshin, Consolidated P&L incl. Special Items and Deferred-Tax Charge — p.11
  3. Isetan Mitsukoshi Holdings — Q2 FY2026 Tanshin, Credit/Finance Segment Commentary — p.6
  4. Isetan Mitsukoshi Holdings — Q2 FY2025 Earnings Call Q&A Summary, "ex-special-items ROE 10%+" target — p.3
  5. Isetan Mitsukoshi Holdings — Q4 FY2026 Earnings Call Q&A Summary, "Shin Kong irregular profit" reference — p.1
  6. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, FY2027 Guidance and CF Overview — p.7
  7. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, Headline Consolidated Results — p.1
  8. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, Goodwill Impairment Disclosure — p.21
  9. Isetan Mitsukoshi Holdings — FY2025 Annual Report, 11-Year Financial Summary — p.97
  10. Isetan Mitsukoshi Holdings — FY2025 Full-Year Tanshin, CF Overview incl. ¥33.8B receivables swing — p.7
  11. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, Consolidated Cash Flow Statement — p.15
  12. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, Investing CF and Shin Kong Proceeds Classification — p.7
  13. Isetan Mitsukoshi Holdings — FY2025 Annual Report, Consolidated Balance Sheet (FY24/FY25) — p.98
  14. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, Consolidated Balance Sheet — p.8
  15. Isetan Mitsukoshi Holdings — Q3 FY2026 Tanshin, MI Card Basic Membership +40% YoY Commentary — p.5
  16. Isetan Mitsukoshi Holdings — FY2025 Annual Report, Consolidated Balance Sheet incl. Reserve Lines — p.98
  17. Isetan Mitsukoshi Holdings — Q3 FY2026 Tanshin, Credit Segment "Bad-debt Reversal Effect" Admission — p.5
  18. Isetan Mitsukoshi Holdings — Q3 FY2026 Tanshin, Impairment Buckets within "Store Closure Losses" — p.13
  19. Isetan Mitsukoshi Holdings — FY2025 Full-Year Tanshin, Effective Tax Rate Detail (FY24 −0.7%) — p.11
  20. Isetan Mitsukoshi Holdings — FY2025 Annual Report, Consolidated P&L Detail (FY24/FY25) — p.99
  21. Isetan Mitsukoshi Holdings — FY2026 Full-Year Tanshin, Subsequent Events — Shin Kong Stake Sale to JV-Partner SPC — p.22
  22. Isetan Mitsukoshi Holdings — FY2025 Annual Securities Report (Yuho), Related-Party Transactions — p.154
  23. Isetan Mitsukoshi Holdings — Q3 FY2026 Earnings Call Q&A Summary, Equity-Method MTM Admission — p.1
  24. Isetan Mitsukoshi Holdings — FY2025 Annual Securities Report (Yuho), Auditor (EY ShinNihon) Tenure Disclosure — p.82
  25. Isetan Mitsukoshi Holdings — FY2025 Annual Securities Report (Yuho), Audit and Non-Audit Fees Schedule — p.83
  26. Isetan Mitsukoshi Holdings — FY2025 Annual Securities Report (Yuho), Board Composition and Independence — p.55